CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- 4 Grant or award Chief Accounting Officer acquired 3,433 shares (grant or award)
- 4 Planned sale CFO and Treasurer sold 10,000 shares at $100.52 ($1,005,200)
- 4 Open-market sale Director sold 3 shares at an average $93.84 ($282)
- 4 Grant or award Chief Commercial Officer acquired 14,928 shares (grant or award)
- 4 Grant or award See Remarks acquired 23,884 shares (grant or award)
- 4 Grant or award CFO and Treasurer acquired 23,884 shares (grant or award)
- 4 Planned sale President sold 2,084 shares at $98.00 ($204,232)
- 4 Grant or award CEO acquired 70,909 shares (grant or award)
- 4 Shares withheld for taxes See Remarks gave up 12,907 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 20,261 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 8,637 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 16,594 shares (to pay taxes)
- 4 Planned sale Director sold 53,107 shares at an average $94.35 ($5,010,734)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 759 shares (to pay taxes)
- 4/A Derivatives Options or other derivatives
- 4 Grant or award Director acquired 563 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 1,000 shares at $94.76 ($94,760)
- 4 Shares withheld for taxes CEO gave up 15,446 shares (to pay taxes)
- 4 Planned sale CFO and Treasurer sold 10,000 shares at $81.20 ($812,000)
Page 4 of 30 · 598 filings